what is the glp 1 GLP-1 Same as Ozempic? Understanding Key Differences GLP-ONE + Receptor Activator
Description
In the landmark 68-week STEP-1 trial, adults with overweight or obesity who reached the 2.4 mg maintenance dose lost roughly 15% of their body weight on average a magnitude that had previously belonged to bariatric surgery, not an injection

Semaglutide 2.4 mg, Tirzepatide 15 mg, and cagrilintide/semaglutide combination result in greater weight loss compared to older anti-obesity medications

The 15 mg dose produced average weight loss exceeding 20%, approaching surgical weight loss results without surgery

Tell your doctor if you have fast or pounding heartbeats while you are resting

If the appearance has changed, do not use the vial
